-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Cap-dependent-endonuclease-IN-4
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/cap-dependent-endonuclease-in-4.gif)
| Category | Influenza Virus |
| Description | Cap-dependent endonuclease-IN-4 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-4 is a polycyclic carbamoylpyridone derivative. Cap-dependent endonuclease-IN-4 selectively blocks the transcriptional process of influenza virus, thus inhibits influenza virus multiplication. Cap-dependent endonuclease-IN-4 has the potential for the research of colds caused by Influenza Viruses. |
Product Information
| Synonyms | Cap-dependent endonuclease-IN-4|HY-109025BS|CS-0374998 |
| Molecular Weight | 572.56 |
| Molecular Formula | C27H23F2N3O7S |
| Canonical SMILES | COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F |
| Purity | ≥98% (HPLC) |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1090 |
| Exact Mass | 572.12875432 |
| Target | Influenza Virus |
| XLogP3-AA | 3.8 |
